Prothena | PRTA - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 10.08 1.53 2026-03
Agios Pharmaceuticals 3.56 0 2026-03
Akebia Therapeutics 1.63K 1.6K 2025-12
ALKERMES 39.33 19.8 2026-03
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Amgen 19.84 5.47 2026-03
Biogen 13.7 0.32 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Exelixis 13.91 588.4 2026-03
Incyte 15.35 0.51 2026-03
Ionis Pharmaceuticals 396.15 79.28 2022-09
Neurocrine Biosciences 28.09 807.38 2026-03
Prothena 22.11 11.37 2022-03
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Vertex Pharmaceuticals 25.82 0.33 2026-03
Xoma 52.12 3.09 2022-09